Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Location contact
giuliano scarcelli, PhD
CONTACT
giuliano scarcelli, PhD
SUB_INVESTIGATOR
NCT Number: NCT02118922
We have developed novel Brillouin microscopy and we are testing its potential for keratoconus and ectasia diagnostics. We plan to perform axial scans of the cornea in human volunteers in order to compare biomechanical properties of Keratoconus vs. Normal corneas and compare biomechanical properties of post-LASIK ectasia vs. normal corneas.
Interested in participating?
Request Info20 year–75 year
All sexes
Observational
Boston, Massachusetts, 02114, United States
Location status: Recruiting
giuliano scarcelli, PhD
CONTACT
giuliano scarcelli, PhD
SUB_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Group I includes healthy subjects with normal appearing corneas, normal topography and pachymetry. Group II includes patients diagnosed as having mild, moderate or advanced keratoconus by our ophthalmology expert on the basis of topography and pachymetry. Group III includes healthy subjects who have undergone LASIK surgery in the past 12 months without complications. Inclusion criteria include normal post-operative topography and pachymetry. Group IV includes patients (age 20 - 60) who have undergone LASIK surgery at least 12 months before the study imaging and have been diagnosed with post-LASIK ectasia based on topography, pachymetry and clinical evaluation.Patients diagnosed with keratoconus. Group V- Volunteers to receive PRK surgery This group includes patients who have been diagnosed with myopia and have been scheduled to undergo PRK surgery. Patients with high astigmatism > 2 diopter, prior ocular surgeries, and those patients taking any ocular medications except seasonal allergy medicine such as ketotifen or artificial tears will be excluded. Group VI-Volunteers to receive LASIK Surgery This group includes myopic patients who are scheduled to receive LASIK surgery. Patients with high astigmatism > 2 diopter, prior ocular surgeries, and those patients taking any ocular medications except seasonal allergy medicine such as ketotifen and artificial tears will be excluded. Group VII- Patients with Fuch's Endothelial Corneal Dystrophy. This group includes subjects who are diagnosed with Fuch's corneal dystrophy, at early, mild and advanced stages. The inclusion also extends to subjects with, and without keratoconus. But this exclude patients with any other corneal disorders other than keratoconus, and/or history of ophthalmological surgeries that may affect endothelium cell status, e.g. cataract surgeries.
Overall Exclusion Criteria for all groups: Volunteers who
Time frame: 2012-2022
Patients will be measured one time only at their imaging session
Contact information is provided by the study sponsor or research team.
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04649177
Arthritis, Arthritis, Rheumatoid
Needham, Massachusetts, United States
View Trial DetailsNCT02834260
Congenital Hereditary Stromal Dystrophy of the Cornea, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Saint-Etienne, France
View Trial DetailsNCT02849808
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases
Besançon, France
View Trial DetailsNCT02875145
Cataract, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Besançon, France
View Trial Details